Premium
Characterization of the reaction products of deoxyguanosine with the anticancer agent BFNU and BFNU‐1,1,1′, 1′ ‐ d 4 in different buffers by high‐performance liquid chromatography/atmospheric pressure ionization tandem mass spectrometry
Author(s) -
Ikonomou Michael G.,
Naghipur Ali,
Lown J. William,
Kebarle Paul
Publication year - 1990
Publication title -
biomedical and environmental mass spectrometry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 121
eISSN - 1096-9888
pISSN - 0887-6134
DOI - 10.1002/bms.1200190709
Subject(s) - chemistry , mass spectrometry , chemical ionization , chromatography , atmospheric pressure chemical ionization , tandem mass spectrometry , high performance liquid chromatography , selected reaction monitoring , electron ionization , triple quadrupole mass spectrometer , guanine , deoxyguanosine , analytical chemistry (journal) , ionization , quadrupole mass analyzer , direct electron ionization liquid chromatography–mass spectrometry interface , ion , organic chemistry , adduct , nucleotide , biochemistry , gene
The products of the reaction of the anticancer agent 1,3‐bis(2‐fluoroethyl)‐1‐nitrosourea (BFNU) and BFNU‐1,1,1′, 1′‐ d 4 with the DNA base deoxyguanosine were characterized by applying high‐performance liquid chromatography (HPLC)/tandem mass spectrometry. The total effluent from the HPLC column was introduced into the atmospheric pressure ionization (API) source of a triple‐quadrupole mass spectrometer via a heated nebulizer. The gasified mixture produced from the heated nebulizer was exposed to corona discharge ionization which led to generation of gas‐phase chemical ionization type of ions. The LC/API mass spectrometry produced ions and the tandem mass spectra allowed unambiguous identification, and assignment of positions of the deuterium atoms, in the products of the reaction under a variety of experimental conditions. The identification and characterization of a variety of 7‐(2′‐haloethyl)guanine derivatives among the reaction products provide confirmation of a proposed mechanism for the action of BFNU on DNA bases.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom